Use of SRSF3 agents for the treatment and/or prevention of neurological conditions, cancer… Grant US-11530258-B2 United States of America 20 Dec 2022
USE OF SRSF3 AGENTS FOR THE TREATMENT AND/OR PREVENTION OF NEUROLOGICAL CONDITIONS, CANCER… Application EP-3710015-A4 European Patent Office 10 Nov 2021
COMPOSITIONS AND METHODS FOR SYNERGISTIC ACTIVATION OF P53 BY MODULATION OF MDM2 AND MDM4-S… Application WO-2019241410-A1 World Intellectual Property Organisation (WIPO) 19 Dec 2019